Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 25, 2004; DOI: 10.1124/jpet.104.068205
0022-3565/04/3111-44-50$20.00
JPET 311:44-50, 2004
CARDIOVASCULAR
The Protective Effect of Superoxide Dismutase Mimetic M40401 on Balloon Injury-Related Neointima Formation: Role of the Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1
Carolina Muscoli,
Iolanda Sacco,
Wanessa Alecce,
Ernesto Palma,
Robert Nisticò,
Nicola Costa,
Fabrizio Clementi,
Domenicantonio Rotiroti,
Francesco Romeo,
Daniela Salvemini,
Jawahar L. Mehta, and
Vincenzo Mollace
Faculty of Pharmacy, University "Magna Graecia", Catanzaro, Italy (C.M., I.S., W.A., E.P., R.N., N.C., D.R., V.M.); Department of Cardiology, University of Rome "Tor Vergata", Rome, Italy (F.C., F.R.); Metaphore Pharmaceutical Inc., St. Louis, Missouri (D.S.); and Division of Cardiovascular Medicine, University of Arkansas for Medical Sciences and VA Medical Center, Little Rock, Arkansas (J.L.M.)
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), the principal receptor for oxidized low-density lipoprotein (ox-LDL) in vascular endothelial cells (ECs), has recently been suggested to exert a pivotal role in atherogenesis, possibly by mediating ox-LDL-evoked endothelial dysfunction. On the other hand, LOX-1 expression seems to strongly correlate with the oxidative stress occurring in the vascular wall of experimentally injured blood vessels. Here, we investigated LOX-1 expression and superoxide generation during neointima formation in a balloon injury rat carotid artery model. To test this, we used M40401 [a manganese(II) complex with a bis(cyclo-hexylpyridine-substituted) macrocyclic ligand], a synthetic superoxide dismutase mimetic that is a selective scavenger of superoxide. The injury was performed inserting the balloon catheter through the rat common carotid artery and after 14 days a histopathological analysis revealed a significant restenosis with smooth muscle cell proliferation and neointima formation that was associated with an enhanced expression of LOX-1, nitrotyrosine (the footprint of peroxynitrite) staining, and lipid peroxidation as assessed by malondialdehyde (MDA) formation. Pretreatment of rats with M40401 (0.510 mg/kg i.p. daily) reduced neointima formation, MDA accumulation, nitrotyrosine staining, and LOX-1 expression. Here, we show that removal of superoxide formation occurring in injured arteries reduces both neointima formation and LOX-1 expression and that this may represent a novel therapeutical approach in the treatment of vascular disorders in which proliferation of vascular smooth muscle cells and ox-LDL-related endothelial cell dysfunction occur.
Received March 10, 2004;
accepted June 25, 2004.
Address correspondence to: Prof. Vincenzo Mollace, Faculty of Pharmacy, University of Catanzaro "Magna Graecia", Complesso Nini' Barbieri, Roccelletta di Borgia, 88100, Catanzaro, Italy. E-mail: mollace{at}libero.it
This article has been cited by other articles:

|
 |

|
 |
 
S. Nambiar, S. Viswanathan, B. Zachariah, N. Hanumanthappa, and Sridhar Gopalakrishna Magadi
Oxidative Stress in Prehypertension: Rationale for Antioxidant Clinical Trials
Angiology,
April 1, 2009;
60(2):
221 - 234.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Rahman
Review: Antioxidant therapeutic advances in COPD
Therapeutic Advances in Respiratory Disease,
December 1, 2008;
2(6):
351 - 374.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Mollace, S. Ragusa, I. Sacco, C. Muscoli, F. Sculco, V. Visalli, E. Palma, S. Muscoli, L. Mondello, P. Dugo, et al.
The Protective Effect of Bergamot Oil Extract on Lecitine-like OxyLDL Receptor-1 Expression in Balloon Injury-related Neointima Formation
Journal of Cardiovascular Pharmacology and Therapeutics,
June 1, 2008;
13(2):
120 - 129.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Pacher, J. S. Beckman, and L. Liaudet
Nitric Oxide and Peroxynitrite in Health and Disease
Physiol Rev,
January 1, 2007;
87(1):
315 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Feletou and P. M. Vanhoutte
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Am J Physiol Heart Circ Physiol,
September 1, 2006;
291(3):
H985 - H1002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Mehta, J. Chen, P. L. Hermonat, F. Romeo, and G. Novelli
Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): A critical player in the development of atherosclerosis and related disorders
Cardiovasc Res,
January 1, 2006;
69(1):
36 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-i. Hinagata, M. Kakutani, T. Fujii, T. Naruko, N. Inoue, Y. Fujita, J. L. Mehta, M. Ueda, and T. Sawamura
Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model
Cardiovasc Res,
January 1, 2006;
69(1):
263 - 271.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.